0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Leptospirosis Vaccine Market Research Report 2026
Published Date: 2026-01-26
|
Report Code: QYRE-Auto-0R18988
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Leptospirosis Vaccine Market Research Report 2024
BUY CHAPTERS

Global Leptospirosis Vaccine Market Research Report 2026

Code: QYRE-Auto-0R18988
Report
2026-01-26
Pages:110
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Leptospirosis Vaccine Market Size

The global Leptospirosis Vaccine market was valued at US$ 348 million in 2025 and is anticipated to reach US$ 544 million by 2032, at a CAGR of 6.7% from 2026 to 2032.

Leptospirosis Vaccine Market

Leptospirosis Vaccine Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Leptospirosis Vaccine competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
The Leptospirosis Vaccine is a vaccine for dogs that protects against leptospirosis, a bacterial disease caused by Leptospira bacteria. This zoonotic disease can infect both animals and humans, and it is transmitted through the urine of infected animals, often contaminating water, soil, and food sources. Dogs that contract leptospirosis can suffer from liver and kidney damage, respiratory issues, and other severe symptoms. In some cases, leptospirosis can be fatal.
The North American market for Leptospirosis Vaccine is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Leptospirosis Vaccine is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Leptospirosis Vaccine include Zoetis, Merck Animal Health, Hipra, Boehringer Ingelheim, Virbac, Elanco, Durvet, NeoTech, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Leptospirosis Vaccine market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Leptospirosis Vaccine. The Leptospirosis Vaccine market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Leptospirosis Vaccine market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Leptospirosis Vaccine manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Leptospirosis Vaccine Market Report

Report Metric Details
Report Name Leptospirosis Vaccine Market
Accounted market size in 2025 US$ 348 million
Forecasted market size in 2032 US$ 544 million
CAGR 6.7%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Inactivated Vaccines
  • Live Attenuated Vaccines
by Application
  • Puppies
  • Adult Dogs
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Zoetis, Merck Animal Health, Hipra, Boehringer Ingelheim, Virbac, Elanco, Durvet, NeoTech
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Leptospirosis Vaccine manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Leptospirosis Vaccine sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Leptospirosis Vaccine Market growing?

Ans: The Leptospirosis Vaccine Market witnessing a CAGR of 6.7% during the forecast period 2026-2032.

What is the Leptospirosis Vaccine Market size in 2032?

Ans: The Leptospirosis Vaccine Market size in 2032 will be US$ 544 million.

Who are the main players in the Leptospirosis Vaccine Market report?

Ans: The main players in the Leptospirosis Vaccine Market are Zoetis, Merck Animal Health, Hipra, Boehringer Ingelheim, Virbac, Elanco, Durvet, NeoTech

What are the Application segmentation covered in the Leptospirosis Vaccine Market report?

Ans: The Applications covered in the Leptospirosis Vaccine Market report are Puppies, Adult Dogs

What are the Type segmentation covered in the Leptospirosis Vaccine Market report?

Ans: The Types covered in the Leptospirosis Vaccine Market report are Inactivated Vaccines, Live Attenuated Vaccines

1 Leptospirosis Vaccine Market Overview
1.1 Product Definition
1.2 Leptospirosis Vaccine by Type
1.2.1 Global Leptospirosis Vaccine Market Value by Type: 2025 vs 2032
1.2.2 Inactivated Vaccines
1.2.3 Live Attenuated Vaccines
1.3 Leptospirosis Vaccine by Application
1.3.1 Global Leptospirosis Vaccine Market Value by Application: 2025 vs 2032
1.3.2 Puppies
1.3.3 Adult Dogs
1.4 Global Leptospirosis Vaccine Market Size Estimates and Forecasts
1.4.1 Global Leptospirosis Vaccine Revenue 2021–2032
1.4.2 Global Leptospirosis Vaccine Sales 2021–2032
1.4.3 Global Leptospirosis Vaccine Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Leptospirosis Vaccine Market Competition by Manufacturers
2.1 Global Leptospirosis Vaccine Sales Market Share by Manufacturers (2021–2026)
2.2 Global Leptospirosis Vaccine Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Leptospirosis Vaccine Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Leptospirosis Vaccine, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Leptospirosis Vaccine, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Leptospirosis Vaccine, Product Types and Applications
2.7 Global Key Manufacturers of Leptospirosis Vaccine, Date of Entry into the Industry
2.8 Global Leptospirosis Vaccine Market Competitive Situation and Trends
2.8.1 Global Leptospirosis Vaccine Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Leptospirosis Vaccine Players Market Share by Revenue
2.8.3 Global Leptospirosis Vaccine Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Leptospirosis Vaccine Market Scenario by Region
3.1 Global Leptospirosis Vaccine Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Leptospirosis Vaccine Sales by Region: 2021–2032
3.2.1 Global Leptospirosis Vaccine Sales by Region: 2021–2026
3.2.2 Global Leptospirosis Vaccine Sales by Region: 2027–2032
3.3 Global Leptospirosis Vaccine Revenue by Region: 2021–2032
3.3.1 Global Leptospirosis Vaccine Revenue by Region: 2021–2026
3.3.2 Global Leptospirosis Vaccine Revenue by Region: 2027–2032
3.4 North America Leptospirosis Vaccine Market Facts & Figures by Country
3.4.1 North America Leptospirosis Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Leptospirosis Vaccine Sales by Country (2021–2032)
3.4.3 North America Leptospirosis Vaccine Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Leptospirosis Vaccine Market Facts & Figures by Country
3.5.1 Europe Leptospirosis Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Leptospirosis Vaccine Sales by Country (2021–2032)
3.5.3 Europe Leptospirosis Vaccine Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Leptospirosis Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Leptospirosis Vaccine Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Leptospirosis Vaccine Sales by Region (2021–2032)
3.6.3 Asia Pacific Leptospirosis Vaccine Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Leptospirosis Vaccine Market Facts & Figures by Country
3.7.1 Latin America Leptospirosis Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Leptospirosis Vaccine Sales by Country (2021–2032)
3.7.3 Latin America Leptospirosis Vaccine Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Leptospirosis Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Leptospirosis Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Leptospirosis Vaccine Sales by Country (2021–2032)
3.8.3 Middle East and Africa Leptospirosis Vaccine Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Leptospirosis Vaccine Sales by Type (2021–2032)
4.1.1 Global Leptospirosis Vaccine Sales by Type (2021–2026)
4.1.2 Global Leptospirosis Vaccine Sales by Type (2027–2032)
4.1.3 Global Leptospirosis Vaccine Sales Market Share by Type (2021–2032)
4.2 Global Leptospirosis Vaccine Revenue by Type (2021–2032)
4.2.1 Global Leptospirosis Vaccine Revenue by Type (2021–2026)
4.2.2 Global Leptospirosis Vaccine Revenue by Type (2027–2032)
4.2.3 Global Leptospirosis Vaccine Revenue Market Share by Type (2021–2032)
4.3 Global Leptospirosis Vaccine Price by Type (2021–2032)
5 Segment by Application
5.1 Global Leptospirosis Vaccine Sales by Application (2021–2032)
5.1.1 Global Leptospirosis Vaccine Sales by Application (2021–2026)
5.1.2 Global Leptospirosis Vaccine Sales by Application (2027–2032)
5.1.3 Global Leptospirosis Vaccine Sales Market Share by Application (2021–2032)
5.2 Global Leptospirosis Vaccine Revenue by Application (2021–2032)
5.2.1 Global Leptospirosis Vaccine Revenue by Application (2021–2026)
5.2.2 Global Leptospirosis Vaccine Revenue by Application (2027–2032)
5.2.3 Global Leptospirosis Vaccine Revenue Market Share by Application (2021–2032)
5.3 Global Leptospirosis Vaccine Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Zoetis
6.1.1 Zoetis Company Information
6.1.2 Zoetis Description and Business Overview
6.1.3 Zoetis Leptospirosis Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Zoetis Leptospirosis Vaccine Product Portfolio
6.1.5 Zoetis Recent Developments/Updates
6.2 Merck Animal Health
6.2.1 Merck Animal Health Company Information
6.2.2 Merck Animal Health Description and Business Overview
6.2.3 Merck Animal Health Leptospirosis Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Merck Animal Health Leptospirosis Vaccine Product Portfolio
6.2.5 Merck Animal Health Recent Developments/Updates
6.3 Hipra
6.3.1 Hipra Company Information
6.3.2 Hipra Description and Business Overview
6.3.3 Hipra Leptospirosis Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Hipra Leptospirosis Vaccine Product Portfolio
6.3.5 Hipra Recent Developments/Updates
6.4 Boehringer Ingelheim
6.4.1 Boehringer Ingelheim Company Information
6.4.2 Boehringer Ingelheim Description and Business Overview
6.4.3 Boehringer Ingelheim Leptospirosis Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Boehringer Ingelheim Leptospirosis Vaccine Product Portfolio
6.4.5 Boehringer Ingelheim Recent Developments/Updates
6.5 Virbac
6.5.1 Virbac Company Information
6.5.2 Virbac Description and Business Overview
6.5.3 Virbac Leptospirosis Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Virbac Leptospirosis Vaccine Product Portfolio
6.5.5 Virbac Recent Developments/Updates
6.6 Elanco
6.6.1 Elanco Company Information
6.6.2 Elanco Description and Business Overview
6.6.3 Elanco Leptospirosis Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Elanco Leptospirosis Vaccine Product Portfolio
6.6.5 Elanco Recent Developments/Updates
6.7 Durvet
6.7.1 Durvet Company Information
6.7.2 Durvet Description and Business Overview
6.7.3 Durvet Leptospirosis Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Durvet Leptospirosis Vaccine Product Portfolio
6.7.5 Durvet Recent Developments/Updates
6.8 NeoTech
6.8.1 NeoTech Company Information
6.8.2 NeoTech Description and Business Overview
6.8.3 NeoTech Leptospirosis Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 NeoTech Leptospirosis Vaccine Product Portfolio
6.8.5 NeoTech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Leptospirosis Vaccine Industry Chain Analysis
7.2 Leptospirosis Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Leptospirosis Vaccine Production Mode & Process Analysis
7.4 Leptospirosis Vaccine Sales and Marketing
7.4.1 Leptospirosis Vaccine Sales Channels
7.4.2 Leptospirosis Vaccine Distributors
7.5 Leptospirosis Vaccine Customer Analysis
8 Leptospirosis Vaccine Market Dynamics
8.1 Leptospirosis Vaccine Industry Trends
8.2 Leptospirosis Vaccine Market Drivers
8.3 Leptospirosis Vaccine Market Challenges
8.4 Leptospirosis Vaccine Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Leptospirosis Vaccine Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Leptospirosis Vaccine Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Leptospirosis Vaccine Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Leptospirosis Vaccine Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Leptospirosis Vaccine Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Leptospirosis Vaccine Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Leptospirosis Vaccine Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Leptospirosis Vaccine Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Leptospirosis Vaccine, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Leptospirosis Vaccine, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Leptospirosis Vaccine, Product Types and Applications
 Table 12. Global Key Manufacturers of Leptospirosis Vaccine, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Leptospirosis Vaccine Companies by Tier (Tier 1, Tier 2, Tier 3), based on Leptospirosis Vaccine Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Leptospirosis Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Leptospirosis Vaccine Sales by Region (K Units), 2021–2026
 Table 18. Global Leptospirosis Vaccine Sales Market Share by Region (2021–2026)
 Table 19. Global Leptospirosis Vaccine Sales by Region (K Units), 2027–2032
 Table 20. Global Leptospirosis Vaccine Sales Market Share by Region (2027–2032)
 Table 21. Global Leptospirosis Vaccine Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Leptospirosis Vaccine Revenue Market Share by Region (2021–2026)
 Table 23. Global Leptospirosis Vaccine Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Leptospirosis Vaccine Revenue Market Share by Region (2027–2032)
 Table 25. North America Leptospirosis Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Leptospirosis Vaccine Sales by Country (K Units), 2021–2026
 Table 27. North America Leptospirosis Vaccine Sales by Country (K Units), 2027–2032
 Table 28. North America Leptospirosis Vaccine Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Leptospirosis Vaccine Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Leptospirosis Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Leptospirosis Vaccine Sales by Country (K Units), 2021–2026
 Table 32. Europe Leptospirosis Vaccine Sales by Country (K Units), 2027–2032
 Table 33. Europe Leptospirosis Vaccine Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Leptospirosis Vaccine Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Leptospirosis Vaccine Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Leptospirosis Vaccine Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Leptospirosis Vaccine Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Leptospirosis Vaccine Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Leptospirosis Vaccine Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Leptospirosis Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Leptospirosis Vaccine Sales by Country (K Units), 2021–2026
 Table 42. Latin America Leptospirosis Vaccine Sales by Country (K Units), 2027–2032
 Table 43. Latin America Leptospirosis Vaccine Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Leptospirosis Vaccine Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Leptospirosis Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Leptospirosis Vaccine Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Leptospirosis Vaccine Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Leptospirosis Vaccine Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Leptospirosis Vaccine Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Leptospirosis Vaccine Sales (K Units) by Type (2021–2026)
 Table 51. Global Leptospirosis Vaccine Sales (K Units) by Type (2027–2032)
 Table 52. Global Leptospirosis Vaccine Sales Market Share by Type (2021–2026)
 Table 53. Global Leptospirosis Vaccine Sales Market Share by Type (2027–2032)
 Table 54. Global Leptospirosis Vaccine Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Leptospirosis Vaccine Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Leptospirosis Vaccine Revenue Market Share by Type (2021–2026)
 Table 57. Global Leptospirosis Vaccine Revenue Market Share by Type (2027–2032)
 Table 58. Global Leptospirosis Vaccine Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Leptospirosis Vaccine Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Leptospirosis Vaccine Sales (K Units) by Application (2021–2026)
 Table 61. Global Leptospirosis Vaccine Sales (K Units) by Application (2027–2032)
 Table 62. Global Leptospirosis Vaccine Sales Market Share by Application (2021–2026)
 Table 63. Global Leptospirosis Vaccine Sales Market Share by Application (2027–2032)
 Table 64. Global Leptospirosis Vaccine Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Leptospirosis Vaccine Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Leptospirosis Vaccine Revenue Market Share by Application (2021–2026)
 Table 67. Global Leptospirosis Vaccine Revenue Market Share by Application (2027–2032)
 Table 68. Global Leptospirosis Vaccine Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Leptospirosis Vaccine Price (US$/Unit) by Application (2027–2032)
 Table 70. Zoetis Company Information
 Table 71. Zoetis Description and Business Overview
 Table 72. Zoetis Leptospirosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Zoetis Leptospirosis Vaccine Product
 Table 74. Zoetis Recent Developments/Updates
 Table 75. Merck Animal Health Company Information
 Table 76. Merck Animal Health Description and Business Overview
 Table 77. Merck Animal Health Leptospirosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Merck Animal Health Leptospirosis Vaccine Product
 Table 79. Merck Animal Health Recent Developments/Updates
 Table 80. Hipra Company Information
 Table 81. Hipra Description and Business Overview
 Table 82. Hipra Leptospirosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. Hipra Leptospirosis Vaccine Product
 Table 84. Hipra Recent Developments/Updates
 Table 85. Boehringer Ingelheim Company Information
 Table 86. Boehringer Ingelheim Description and Business Overview
 Table 87. Boehringer Ingelheim Leptospirosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Boehringer Ingelheim Leptospirosis Vaccine Product
 Table 89. Boehringer Ingelheim Recent Developments/Updates
 Table 90. Virbac Company Information
 Table 91. Virbac Description and Business Overview
 Table 92. Virbac Leptospirosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. Virbac Leptospirosis Vaccine Product
 Table 94. Virbac Recent Developments/Updates
 Table 95. Elanco Company Information
 Table 96. Elanco Description and Business Overview
 Table 97. Elanco Leptospirosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. Elanco Leptospirosis Vaccine Product
 Table 99. Elanco Recent Developments/Updates
 Table 100. Durvet Company Information
 Table 101. Durvet Description and Business Overview
 Table 102. Durvet Leptospirosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. Durvet Leptospirosis Vaccine Product
 Table 104. Durvet Recent Developments/Updates
 Table 105. NeoTech Company Information
 Table 106. NeoTech Description and Business Overview
 Table 107. NeoTech Leptospirosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. NeoTech Leptospirosis Vaccine Product
 Table 109. NeoTech Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Leptospirosis Vaccine Distributors List
 Table 113. Leptospirosis Vaccine Customers List
 Table 114. Leptospirosis Vaccine Market Trends
 Table 115. Leptospirosis Vaccine Market Drivers
 Table 116. Leptospirosis Vaccine Market Challenges
 Table 117. Leptospirosis Vaccine Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Leptospirosis Vaccine
 Figure 2. Global Leptospirosis Vaccine Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Leptospirosis Vaccine Market Share by Type: 2025 & 2032
 Figure 4. Inactivated Vaccines Product Picture
 Figure 5. Live Attenuated Vaccines Product Picture
 Figure 6. Global Leptospirosis Vaccine Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Leptospirosis Vaccine Market Share by Application: 2025 & 2032
 Figure 8. Puppies
 Figure 9. Adult Dogs
 Figure 10. Global Leptospirosis Vaccine Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 11. Global Leptospirosis Vaccine Market Size (US$ Million), 2021–2032
 Figure 12. Global Leptospirosis Vaccine Sales (K Units), 2021–2032
 Figure 13. Global Leptospirosis Vaccine Average Price (US$/Unit), 2021–2032
 Figure 14. Leptospirosis Vaccine Report Years Considered
 Figure 15. Leptospirosis Vaccine Sales Share by Manufacturers in 2025
 Figure 16. Global Leptospirosis Vaccine Revenue Share by Manufacturers in 2025
 Figure 17. Top 5 and Top 10 Global Leptospirosis Vaccine Players: Market Share by Revenue in Leptospirosis Vaccine in 2025
 Figure 18. Leptospirosis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 19. Global Leptospirosis Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 20. North America Leptospirosis Vaccine Sales Market Share by Country (2021–2032)
 Figure 21. North America Leptospirosis Vaccine Revenue Market Share by Country (2021–2032)
 Figure 22. United States Leptospirosis Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 23. Canada Leptospirosis Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Europe Leptospirosis Vaccine Sales Market Share by Country (2021–2032)
 Figure 25. Europe Leptospirosis Vaccine Revenue Market Share by Country (2021–2032)
 Figure 26. Germany Leptospirosis Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 27. France Leptospirosis Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. U.K. Leptospirosis Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. Italy Leptospirosis Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Russia Leptospirosis Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Asia Pacific Leptospirosis Vaccine Sales Market Share by Region (2021–2032)
 Figure 32. Asia Pacific Leptospirosis Vaccine Revenue Market Share by Region (2021–2032)
 Figure 33. China Leptospirosis Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Japan Leptospirosis Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. South Korea Leptospirosis Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. India Leptospirosis Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. Australia Leptospirosis Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. China Taiwan Leptospirosis Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Southeast Asia Leptospirosis Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Latin America Leptospirosis Vaccine Sales Market Share by Country (2021–2032)
 Figure 41. Latin America Leptospirosis Vaccine Revenue Market Share by Country (2021–2032)
 Figure 42. Mexico Leptospirosis Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Brazil Leptospirosis Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Argentina Leptospirosis Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Colombia Leptospirosis Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Middle East and Africa Leptospirosis Vaccine Sales Market Share by Country (2021–2032)
 Figure 47. Middle East and Africa Leptospirosis Vaccine Revenue Market Share by Country (2021–2032)
 Figure 48. Turkey Leptospirosis Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Saudi Arabia Leptospirosis Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. UAE Leptospirosis Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Global Sales Market Share of Leptospirosis Vaccine by Type (2021–2032)
 Figure 52. Global Revenue Market Share of Leptospirosis Vaccine by Type (2021–2032)
 Figure 53. Global Leptospirosis Vaccine Price (US$/Unit) by Type (2021–2032)
 Figure 54. Global Sales Market Share of Leptospirosis Vaccine by Application (2021–2032)
 Figure 55. Global Revenue Market Share of Leptospirosis Vaccine by Application (2021–2032)
 Figure 56. Global Leptospirosis Vaccine Price (US$/Unit) by Application (2021–2032)
 Figure 57. Leptospirosis Vaccine Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners